• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓解期溃疡性结肠炎患者的贫血:一项来自印度西部的研究。

Anemia in patients with ulcerative colitis in remission: A study from western India.

作者信息

Chaubal Alisha, Pandey Vikas, Choksi Dhaval, Poddar Prateik, Ingle Meghraj, Phadke Aniruddha, Sawant Prabha

机构信息

Department of Gastroenterology, Lokmanya Tilak Medical College, Dr. Babasaheb Ambedkar Road, Sion West, Mumbai, 400 022, India.

出版信息

Indian J Gastroenterol. 2017 Sep;36(5):361-365. doi: 10.1007/s12664-017-0791-z. Epub 2017 Oct 9.

DOI:10.1007/s12664-017-0791-z
PMID:28993978
Abstract

BACKGROUND

Anemia is common in patients with active ulcerative colitis. We aimed to study the anemia profile in patients with ulcerative colitis in clinical remission.

METHODS

Sixty-four patients with ulcerative colitis and with a clinical Mayo score less than 3 for at least 3 months were evaluated for anemia. Initial screening was done by hemogram and only patients with anemia were evaluated further for the cause of anemia. We also screened a control population for anemia. Patients with mild anemia were given oral iron, moderate anemia were given intravenous iron and severe anemia were given blood transfusion.

RESULTS

The mean hemoglobin in ulcerative colitis patients was 11.75 g/dL and in controls was 13.1 g/dL (p=0.011). The prevalence of anemia was 53.1% in the ulcerative colitis patients and 13.3% in the controls (p=<0.001). 58.8% had mild anemia, 29.4% had moderate anemia and 8.8% had severe anemia. Iron deficiency was the most common cause of anemia (70.5%) followed by anemia of chronic disease combined with iron deficiency in 23.5%. Ferritin levels did not correlate with hemoglobin levels. Oral iron increased the hemoglobin by 1.4 g/dL and intravenous iron by 2.2 g/dL at 1 month.

CONCLUSION

Anemia was seen in more than half of patients with ulcerative colitis in clinical remission, iron deficiency being the most common cause.

摘要

背景

贫血在活动性溃疡性结肠炎患者中很常见。我们旨在研究临床缓解期溃疡性结肠炎患者的贫血情况。

方法

对64例溃疡性结肠炎患者进行评估,这些患者的临床梅奥评分至少3个月低于3分,评估其是否贫血。最初通过血常规进行筛查,仅对贫血患者进一步评估贫血原因。我们还对对照组人群进行贫血筛查。轻度贫血患者给予口服铁剂,中度贫血患者给予静脉铁剂,重度贫血患者给予输血治疗。

结果

溃疡性结肠炎患者的平均血红蛋白为11.75 g/dL,对照组为13.1 g/dL(p = 0.011)。溃疡性结肠炎患者的贫血患病率为53.1%,对照组为13.3%(p < 0.001)。58.8%为轻度贫血,29.4%为中度贫血,8.8%为重度贫血。缺铁是贫血最常见的原因(70.5%),其次是慢性病贫血合并缺铁,占23.5%。铁蛋白水平与血红蛋白水平无关。口服铁剂在1个月时使血红蛋白升高1.4 g/dL,静脉铁剂使血红蛋白升高2.2 g/dL。

结论

超过一半的临床缓解期溃疡性结肠炎患者存在贫血,缺铁是最常见的原因。

相似文献

1
Anemia in patients with ulcerative colitis in remission: A study from western India.缓解期溃疡性结肠炎患者的贫血:一项来自印度西部的研究。
Indian J Gastroenterol. 2017 Sep;36(5):361-365. doi: 10.1007/s12664-017-0791-z. Epub 2017 Oct 9.
2
Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.溃疡性结肠炎贫血的静脉铁剂与促红细胞生成素序贯治疗
Digestion. 1999;60(3):262-7. doi: 10.1159/000007667.
3
[Frequency of anemia in ulcerative colitis in children].[儿童溃疡性结肠炎中贫血的发生率]
Pol Merkur Lekarski. 2012 Sep;33(195):138-42.
4
Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.土耳其炎症性肠病患者贫血的频率、类型和治疗方法。
World J Gastroenterol. 2018 Sep 28;24(36):4186-4196. doi: 10.3748/wjg.v24.i36.4186.
5
Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients.基于人群的炎症性肠病队列(ICURE)中的贫血:1年后患病率仍很高,尤其是在儿科患者中。
Inflamm Bowel Dis. 2014 Dec;20(12):2266-70. doi: 10.1097/MIB.0000000000000191.
6
Replacement Resistant Iron Deficiency Anemia in a Patient With Ulcerative Colitis in Remission: Investigating Beyond the Obvious.缓解期溃疡性结肠炎患者难治性缺铁性贫血:深入探究表象之外的原因
Inflamm Bowel Dis. 2019 Sep 18;25(10):e123-e124. doi: 10.1093/ibd/izz152.
7
Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.炎症性肠病的口服和静脉铁剂治疗:血液学反应及生活质量改善
Inflamm Bowel Dis. 2009 Oct;15(10):1485-91. doi: 10.1002/ibd.20925.
8
ANEMIA IN INFLAMMATORY BOWEL DISEASE MORE THAN AN EXTRAINTESTINAL COMPLICATION.炎症性肠病中的贫血:不仅仅是一种肠外并发症
Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):34-9.
9
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia.斯堪的纳维亚半岛炎症性肠病门诊患者贫血和缺铁的患病率。
Scand J Gastroenterol. 2011 Mar;46(3):304-9. doi: 10.3109/00365521.2010.533382. Epub 2010 Nov 15.
10
Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.无贫血情况下的缺铁会损害炎症性肠病患者对健康相关生活质量的感知。
Inflamm Bowel Dis. 2016 Jun;22(6):1450-5. doi: 10.1097/MIB.0000000000000768.

引用本文的文献

1
Inflammatory bowel disease in south Asia: a scoping review.南亚的炎症性肠病:一项范围综述。
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):259-274. doi: 10.1016/S2468-1253(24)00341-8.
2
Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial.螺旋藻补充剂对溃疡性结肠炎患者的影响:一项双盲、安慰剂对照随机试验。
BMC Complement Med Ther. 2024 Feb 29;24(1):109. doi: 10.1186/s12906-024-04400-w.
3
Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.

本文引用的文献

1
Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.炎症性肠病诊断时的贫血:青少年及成年患者中的患病率及相关因素
Dig Liver Dis. 2017 Apr;49(4):405-411. doi: 10.1016/j.dld.2016.12.005. Epub 2016 Dec 14.
2
Factors Predicting Testing and Treatment of Iron Deficiency in a Nationwide Cohort of Anemic UC Patients.全国性贫血性溃疡性结肠炎患者队列中铁缺乏检测与治疗的预测因素
Inflamm Bowel Dis. 2016 Dec;22(12):2894-2901. doi: 10.1097/MIB.0000000000000947.
3
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.
溃疡性结肠炎患者结肠中 DMT1 和 FPN1 表达增加,铁吸收增强。
Am J Physiol Cell Physiol. 2020 Feb 1;318(2):C263-C271. doi: 10.1152/ajpcell.00128.2019. Epub 2019 Nov 13.
欧洲关于炎症性肠病中铁缺乏症和贫血症诊断与管理的共识
J Crohns Colitis. 2015 Mar;9(3):211-22. doi: 10.1093/ecco-jcc/jju009. Epub 2014 Dec 3.
4
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.一项多中心、随机、阳性药物对照研究,旨在评估静脉注射羧甲麦芽糖铁治疗缺铁性贫血患者的疗效和安全性。
Transfusion. 2014 Feb;54(2):306-15. doi: 10.1111/trf.12289. Epub 2013 Jun 17.
5
Diagnosing anemia in inflammatory bowel disease: beyond the established markers.诊断炎症性肠病中的贫血:超越既定标志物。
J Crohns Colitis. 2011 Oct;5(5):381-91. doi: 10.1016/j.crohns.2011.03.010. Epub 2011 Apr 27.
6
Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.改善慢性病贫血和缺铁性贫血的鉴别诊断:可溶性转铁蛋白受体和 sTfR/铁蛋白指数的前瞻性多中心评估。
Am J Hematol. 2011 Nov;86(11):923-7. doi: 10.1002/ajh.22108. Epub 2011 Aug 2.
7
FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.FERGIcor 研究:一项评估羧基麦芽糖铁治疗炎症性肠病缺铁性贫血的随机对照试验
Gastroenterology. 2011 Sep;141(3):846-853.e1-2. doi: 10.1053/j.gastro.2011.06.005. Epub 2011 Jun 12.
8
Diagnosis and management of iron deficiency anemia in patients with IBD.炎症性肠病患者铁缺乏症的诊断和治疗。
Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):599-610. doi: 10.1038/nrgastro.2010.151. Epub 2010 Oct 5.
9
Anemia and inflammatory bowel diseases.贫血与炎症性肠病。
World J Gastroenterol. 2009 Oct 7;15(37):4659-65. doi: 10.3748/wjg.15.4659.
10
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.炎症性肠病贫血诊断与管理中的常见误解
Am J Gastroenterol. 2008 May;103(5):1299-307. doi: 10.1111/j.1572-0241.2008.01846.x.